{"data":{"id":"us-ok/okla.-stat.-tit.-56-56-204","jurisdiction":"us-ok","citation":"Okla. Stat. tit. 56, § 56-204","heading":"Vendor drug program - Exemption of certain drugs","body":"A. Except as otherwise provided, the Oklahoma Health Care\n\nAuthority shall be authorized and directed to establish a vendor\n\ndrug program to provide any drugs that have been approved and\n\ndesignated as safe and effective by the federal Food and Drug\n\nAdministration, and that are prescribed by a licensed medical,\n\ndental, podiatric or osteopathic practitioner for eligible\n\nrecipients of assistance payments suffering from painful or life-\n\nendangering diseases or other persons who are suffering from a\n\ncatastrophic illness.\n\nB. The Authority shall, in accordance with federal law, not be\n\nobligated to cover any outpatient drugs of a manufacturer which has\n\nnot entered into or which does not have in effect a rebate agreement\n\nwith the Secretary of Health and Human Services on behalf of the\n\nstate.\n\nC. Such program shall, to the fullest extent possible, be\n\nestablished and maintained in conjunction with existing federal\n\nprograms of prescribed drugs so as to earn the maximum of federal\n\nfinancial participation. Exempt from the provisions of this section\n\nare the following drugs or classes of drugs, or their medical uses:\n\n1. Agents when used for anorexia or weight gain;\n\n2. Agents when used to promote fertility;\n\n3. Agents when used for cosmetic purposes or hair growth;\n\n4. Agents when used for the symptomatic relief of coughs and\n\ncolds;\n\n5. Agents when used to promote smoking cessation;\n\n6. Prescription vitamins and mineral products, except prenatal\n\nvitamins and fluoride preparations;\n\n7. Nonprescription drugs;\n\n8. Covered outpatient drugs when the manufacturer seeks to\n\nrequire as a condition of sale that associated tests or monitoring\n\nservices be purchased exclusively from the manufacturer or its\n\ndesignee;\n\n9. Drugs described in paragraph 3 of subsection c of Section\n\n107 of the Drug Amendments of 1962, 21 U.S.C., Section 107(c)(3),\n\nand identical, similar or related drugs, within the meaning of\n\nparagraph 1 of subsection b of Section 310.6 of Title 21 of the Code\n\nof Federal Regulations;\n\n10. Barbiturates; or\n\n11. Benzodiazepines;\n\nprovided, however, the Authority shall be authorized to include\n\nspecific drugs within these categories for reimbursement based upon\n\nspecific medical need.\n\nD. The Authority shall be authorized to establish a prospective\n\ndrug utilization review program for the H2 Antagonists; provided\n\nthat such limitations are in compliance with federal Food and Drug\n\nAdministration Agency-approved product labeling.","path":["OK Code","Title 56"],"source_url":"https://www.oklegislature.gov/OK_Statutes/CompleteTitles/os56.pdf","current_through":"2026-08-14","vintage":"open-us-law v2026.08, retrieved 2026-09-14","retrieved_at":"2026-09-14T18:32:36Z","sha256":"d34f617f83eac6a2342d8d04457ac98b095d9984a1e2830d2c8dc2413c96821a","source_id":"us-ok","stale":false,"prev":"us-ok/okla.-stat.-tit.-56-56-203","next":"us-ok/okla.-stat.-tit.-56-56-204.1"},"notice":"GroundRules: Original legal text. Not legal advice."}